- Home
- ATGL vs ORGO Comparison
ATGL vs ORGO Comparison
Compare ATGL & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATGL
- ORGO
- Stock Information
- Founded
- ATGL 2017
- ORGO 1985
- Country
- ATGL Hong Kong
- ORGO United States
- Employees
- ATGL N/A
- ORGO N/A
- Industry
- ATGL
- ORGO Biotechnology: Pharmaceutical Preparations
- Sector
- ATGL
- ORGO Health Care
- Exchange
- ATGL Nasdaq
- ORGO Nasdaq
- Market Cap
- ATGL 407.0M
- ORGO 384.4M
- IPO Year
- ATGL 2023
- ORGO N/A
- Fundamental
- Price
- ATGL $24.00
- ORGO $3.25
- Analyst Decision
- ATGL
- ORGO Buy
- Analyst Count
- ATGL 0
- ORGO 2
- Target Price
- ATGL N/A
- ORGO $5.50
- AVG Volume (30 Days)
- ATGL 3.4K
- ORGO 911.8K
- Earning Date
- ATGL 12-31-2024
- ORGO 08-07-2025
- Dividend Yield
- ATGL N/A
- ORGO N/A
- EPS Growth
- ATGL N/A
- ORGO N/A
- EPS
- ATGL N/A
- ORGO N/A
- Revenue
- ATGL $1,590,148.00
- ORGO $458,760,000.00
- Revenue This Year
- ATGL N/A
- ORGO $2.62
- Revenue Next Year
- ATGL N/A
- ORGO $12.46
- P/E Ratio
- ATGL N/A
- ORGO N/A
- Revenue Growth
- ATGL 42.17
- ORGO 5.35
- 52 Week Low
- ATGL $1.15
- ORGO $2.28
- 52 Week High
- ATGL $57.32
- ORGO $6.71
- Technical
- Relative Strength Index (RSI)
- ATGL 37.63
- ORGO 48.02
- Support Level
- ATGL $24.88
- ORGO $3.08
- Resistance Level
- ATGL $27.05
- ORGO $3.71
- Average True Range (ATR)
- ATGL 0.48
- ORGO 0.21
- MACD
- ATGL -0.12
- ORGO 0.07
- Stochastic Oscillator
- ATGL 0.00
- ORGO 55.45
About ATGL Alpha Technology Group Limited
Alpha Technology Group Ltd operates through its subsidiaries, which are established cloud-based IT solution service providers in Hong Kong. Its Operating Subsidiaries utilize its analytic skills, programming skills, artificial intelligence technologies and technological know-how to provide comprehensive solutions designed to optimize the business performance of customers, meet various industry-specific operational challenges of customers and create new business opportunities for customers. The Operating Subsidiaries provide services for customers from a variety of industries, including consulting, real estate, architectural design, carpark management, electronic payment services, logistics, investments, retail, textiles, wholesale and distribution, etc.
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.